Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK ((SELNET))
Observational Study, for Quality Assessment, of Sarcoma As a Model to Improve Diagnosis and Clinical Care of Rare Tumors Through a European and Latin American Multidisciplinary NETWORK
Sponsor: Grupo Espanol de Investigacion en Sarcomas
This observational or N/A phase trial investigates Bone Sarcoma and Gastrointestinal Stromal Tumors and is currently actively recruiting participants. Grupo Espanol de Investigacion en Sarcomas leads this study, which shows 11 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Apr 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
-
Apr 2023 — Feb 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
▶ Show 6 earlier versions
-
Mar 2023 — Apr 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Mar 2023 [monthly]
Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jan 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Grupo Espanol de Investigacion en Sarcomas
For direct contact, visit the study record on ClinicalTrials.gov .